Healios Financial Statements From 2010 to 2025
| HLOSF Stock | USD 1.93 0.38 16.45% |
Check Healios KK financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Healios KK's main balance sheet or income statement drivers, such as , as well as many indicators such as . Healios financial statements analysis is a perfect complement when working with Healios KK Valuation or Volatility modules.
Healios |
Healios KK Company Operating Margin Analysis
Healios KK's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Healios KK Operating Margin | (136.90) % |
Most of Healios KK's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Healios KK is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Healios KK has an Operating Margin of -136.9024%. This is 290.26% higher than that of the Healthcare sector and 22.16% higher than that of the Biotechnology industry. The operating margin for all United States stocks is notably higher than that of the company.
Healios KK Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Healios KK's current stock value. Our valuation model uses many indicators to compare Healios KK value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Healios KK competition to find correlations between indicators driving Healios KK's intrinsic value. More Info.Healios KK is rated below average in return on equity category among its peers. It is rated # 4 in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Healios KK's earnings, one of the primary drivers of an investment's value.About Healios KK Financial Statements
Healios KK stakeholders use historical fundamental indicators, such as Healios KK's revenue or net income, to determine how well the company is positioned to perform in the future. Although Healios KK investors may analyze each financial statement separately, they are all interrelated. For example, changes in Healios KK's assets and liabilities are reflected in the revenues and expenses on Healios KK's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Healios KK. Please read more on our technical analysis and fundamental analysis pages.
Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. Healios K.K. was incorporated in 2011 and is headquartered in Tokyo, Japan. Healios K is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Healios Pink Sheet
Healios KK financial ratios help investors to determine whether Healios Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Healios with respect to the benefits of owning Healios KK security.